US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist

3.280
+0.120+3.80%

Close Feb 28 16:00 ET

3.280
0.0000.00%

Post 16:15 ET

281.06MMarket Cap-0.86P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amylyx Pharmaceuticals Q4 2024 Estimates Date

Currency：USDMar 4, 2025

	Estimate	YoY
Revenue	0	-100.00%
EPS	-0.52	-842.71%

Analyst Rating

Buy

Feb 28, 2025

Amylyx Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
Mar 4, 2025	2024/Q4	-- / 0.000	--
Nov 7, 2024	2024/Q3	416.000K / 0.000	--
Aug 8, 2024	2024/Q2	-1.023M / 8.530M	--
May 9, 2024	2024/Q1	88.643M / 98.346M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

Mar 4, 20252024/Q4-- / 0.000--

Nov 7, 20242024/Q3416.000K / 0.000--

Aug 8, 20242024/Q2-1.023M / 8.530M--

May 9, 20242024/Q188.643M / 98.346M--

Unlock Free Earnings Estimates

Open Account

Amylyx Pharmaceuticals Earnings Reports

Amylyx Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 08:28 ET

Amylyx Pharmaceuticals | 8-K: Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 7, 2024 07:09 ET

Amylyx Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 07:19 ET

Amylyx Pharmaceuticals | 8-K: Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 8, 2024 07:14 ET